Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna hgf ltd
operating since 1995
1166.31
Headquarter in Leeds and 13 offices
active in Legal Services and IP Consulting

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Michael Andrew Nelson has worked on the following 9 EPO patent applications which have been published in the last five years:

EP12173377

Manufacture of multiple minicapsules

IPC classification:
A61K 9/16, A61K 9/50, B01J 13/04
Agent:
Harrison Goddard Foote LLP
Agent:
Michael Andrew Nelson, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP12710503

COMPOSITION COMPRISING A DIINDOLYLMETHANE AND A RETINOID TO TREAT A SKIN CONDITION

IPC classification:
A61K 31/07, A61K 31/203, A61K 31/216, A61K 31/404, A61K 45/06, A61P 17/10
Agent:
Michael Andrew Nelson, HGF Limited
Agent:
Christopher Michael Hill, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP10840065

METHOD OF REDUCING INCIDENCE OF INTRAOCULAR PRESSURE ASSOCIATED WITH INTRAOCULAR USE OF CORTICOSTEROIDS

IPC classification:
A61K 31/573
Agent:
Michael Andrew Nelson, HGF Limited
Agent:
Nina Louise White, Boult Wade Tennant Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12168409

Combined therapy for cystic fibrosis

IPC classification:
A61K 31/047, A61K 31/05, A61K 31/13, A61K 31/192, A61K 31/198, A61K 31/47, A61P 11/00
Agent:
Paolo Banfi, Bianchetti Bracco Minoja Srl
Agent:
Michael Andrew Nelson, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP12853238

SWIMWEAR DESIGN AND CONSTRUCTION

IPC classification:
A41D 13/012
Agent:
Stefan Käck, Kahler Käck Mollekopf
Agent:
Michael Andrew Nelson, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP14732406

4-(5-(4-CHLOROPHENYL)-2-(2-CYCLOPROPYLACETYL)-1,4-DIMETHYL-1H-PYRROL-3-YL)BENZENESULFONAMIDE AS ALPHA 7 NACHR MODULATOR

IPC classification:
A61K 31/40, A61P 25/16, A61P 25/18, A61P 25/28, C07D 207/333
Applicant:
Lupin Limited
Agent:
Multiple attorneys, HGF Limited
Status:
EXAMINATION IN PROGRESS
EP14825055

INTRANASAL NALOXONE COMPOSITIONS AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 9/00, A61K 31/485, A61K 47/10, A61K 47/12, A61K 47/18, A61P 25/36
Agent:
Michael Andrew Nelson, HGF Limited
Agent:
Samson & Partner Patentanwälte mbB
Status:
EXAMINATION REQUESTED
EP15728978

PROCESS FOR FABRICATION OF ENHANCED "-ALUMINA SOLID ELECTROLYTES FOR ENERGY STORAGE DEVICES AND ENERGY APPLICATIONS

IPC classification:
C01F 7/02, C01F 17/00, C01G 25/00, C01G 25/02, C04B 35/113, H01M 10/054, H01M 10/0562, H01M 10/39
Applicant:
Battelle Memorial Institute
Agent:
Michael Andrew Nelson, HGF Limited
Status:
EXAMINATION REQUESTED
EP15790229

DOPAMINE D3 RECEPTOR ANTAGONISTS COMPOUNDS

IPC classification:
A61K 31/4196, A61K 31/422, A61K 31/4412, A61P 25/12, C07D 401/14, C07D 403/12, C07D 403/14, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/14
Agent:
Michael Andrew Nelson, HGF Limited
Status:
Request for examination was made

Please Sign in to use this feature